Argenica Therapeutics dose test raises hopes for stroke victims
Argenica Therapeutics (ASX:AGN), a biotech firm focused on the advancement of therapies…
Argenica Therapeutics Limited (ASX:AGN)
About Argenica Therapeutics Limited
Key Information
AGN In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 24/04/2024 | Price Sensitive PS Quarterly Activities/Appendix 4C Cash Flow Report | 375.6KB | 406 |
| 22/04/2024 | Cleansing Notice | 178.19KB | 153 |
| 22/04/2024 | Application for quotation of securities - AGN | 15.55KB | 1.0K |
| 12/04/2024 | Proposed issue of securities - AGN | 16.9KB | 173 |
| 12/04/2024 | Proposed issue of securities - AGN | 15.74KB | 169 |
| 12/04/2024 | Price Sensitive PS Argenica Successfully Completes $12.0m Placement | 224.26KB | 12K |
| 10/04/2024 | Price Sensitive PS Trading Halt | 298.63KB | 5.9K |
| 10/04/2024 | Price Sensitive PS Patient Dosing Milestone Achieved in Phase 2 Stroke Trial | 275.78KB | 873 |